These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

570 related items for PubMed ID: 29183284

  • 1. Robust expression of tumor suppressor miRNA's let-7 and miR-195 detected in plasma of Saudi female breast cancer patients.
    Qattan A, Intabli H, Alkhayal W, Eltabache C, Tweigieri T, Amer SB.
    BMC Cancer; 2017 Nov 28; 17(1):799. PubMed ID: 29183284
    [Abstract] [Full Text] [Related]

  • 2. Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer.
    Thakur S, Grover RK, Gupta S, Yadav AK, Das BC.
    PLoS One; 2016 Nov 28; 11(7):e0158946. PubMed ID: 27404381
    [Abstract] [Full Text] [Related]

  • 3. Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer.
    McAnena P, Tanriverdi K, Curran C, Gilligan K, Freedman JE, Brown JAL, Kerin MJ.
    BMC Cancer; 2019 May 10; 19(1):436. PubMed ID: 31077182
    [Abstract] [Full Text] [Related]

  • 4. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.
    Li HY, Liang JL, Kuo YL, Lee HH, Calkins MJ, Chang HT, Lin FC, Chen YC, Hsu TI, Hsiao M, Ger LP, Lu PJ.
    Breast Cancer Res; 2017 Dec 19; 19(1):133. PubMed ID: 29258605
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Aberrant miRNAs expressed in HER-2 negative breast cancers patient.
    Braicu C, Raduly L, Morar-Bolba G, Cojocneanu R, Jurj A, Pop LA, Pileczki V, Ciocan C, Moldovan A, Irimie A, Eniu A, Achimas-Cadariu P, Paradiso A, Berindan-Neagoe I.
    J Exp Clin Cancer Res; 2018 Oct 20; 37(1):257. PubMed ID: 30342533
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Circulating miRNAs revealed as surrogate molecular signatures for the early detection of breast cancer.
    Mishra S, Srivastava AK, Suman S, Kumar V, Shukla Y.
    Cancer Lett; 2015 Dec 01; 369(1):67-75. PubMed ID: 26276721
    [Abstract] [Full Text] [Related]

  • 11. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
    Chen X, Xu Y, Liao X, Liao R, Zhang L, Niu K, Li T, Li D, Chen Z, Duan Y, Sun J.
    Tumour Biol; 2016 Sep 01; 37(9):11927-11936. PubMed ID: 27075472
    [Abstract] [Full Text] [Related]

  • 12. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Zhang K, Wang YW, Wang YY, Song Y, Zhu J, Si PC, Ma R.
    Gene; 2017 Jul 01; 619():10-20. PubMed ID: 28359916
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.
    Schrauder MG, Strick R, Schulz-Wendtland R, Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A, Hein A, Bayer CM, Bani MR, Richter S, Adamietz BR, Wenkel E, Rauh C, Beckmann MW, Fasching PA.
    PLoS One; 2012 Jul 01; 7(1):e29770. PubMed ID: 22242178
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.
    Matamala N, Vargas MT, González-Cámpora R, Miñambres R, Arias JI, Menéndez P, Andrés-León E, Gómez-López G, Yanowsky K, Calvete-Candenas J, Inglada-Pérez L, Martínez-Delgado B, Benítez J.
    Clin Chem; 2015 Aug 01; 61(8):1098-106. PubMed ID: 26056355
    [Abstract] [Full Text] [Related]

  • 19. The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs.
    Bahrami A, Aledavood A, Anvari K, Hassanian SM, Maftouh M, Yaghobzade A, Salarzaee O, ShahidSales S, Avan A.
    J Cell Physiol; 2018 Feb 01; 233(2):774-786. PubMed ID: 28109133
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.